β-carotene: A cancer chemopreventive agent or a co-carcinogen?

Moreno Paolini, Sherif Abdel-Rahman, Andrea Sapone, Gian Franco Pedulli, Paolo Perocco, Giorgio Cantelli-Forti, Marvin S. Legator

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Evidence from both epidemiological and experimental observations have fueled the belief that the high consumption of fruits and vegetables rich in carotenoids may help prevent cancer and heart disease in humans. Because of its well-documented antioxidant and antigenotoxic properties, the carotenoid β-carotene (βCT) gained most of the attention in the early 1980s and became one of the most extensively studied cancer chemopreventive agents in population-based trials supported by the National Cancer Institute. However, the results of three randomized lung cancer chemoprevention trials on βCT supplementation unexpectedly contradicted the large body of epidemiological evidence relating to the potential benefits of dietary carotenoids. Not only did βCT show no benefit, it was associated with significant increases in lung cancer incidence, cardiovascular diseases, and total mortality. These findings aroused widespread scientific debate that is still ongoing. It also raised the suspicion that βCT may even possess co-carcinogenic properties. In this review, we summarize the current data on the co-carcinogenic properties of βCT that is attributed to its role in the induction of carcinogen metabolizing enzymes and the over-generation of oxidative stress. The data presented provide convincing evidence of the harmful properties of this compound if given alone to smokers, or to individuals exposed to environmental carcinogens, as a micronutrient supplement. This has now been directly verified in a medium-term cancer transformation bioassay. In the context of public health policies, while the benefits of a diet rich in a variety of fruits and vegetables should continue to be emphasized, the data presented here point to the need for consideration of the possible detrimental effects of certain isolated dietary supplements, before mass cancer chemoprevention clinical trials are conducted on human subjects. This is especially important for genetically predisposed individuals who are environmentally or occupationally exposed to mutagens and carcinogens, such as those found in tobacco smoke and in industrial settings.

Original languageEnglish (US)
Pages (from-to)195-200
Number of pages6
JournalMutation Research - Reviews in Mutation Research
Volume543
Issue number3
DOIs
StatePublished - Jun 2003

Fingerprint

Carotenoids
Carcinogens
Neoplasms
Chemoprevention
Vegetables
Fruit
Lung Neoplasms
Environmental Carcinogens
National Cancer Institute (U.S.)
Micronutrients
Mutagens
Public Policy
Dietary Supplements
Health Policy
Smoke
Biological Assay
Tobacco
Heart Diseases
Oxidative Stress
Cardiovascular Diseases

Keywords

  • β-Carotene
  • Cancer
  • Chemopreventive agent

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis

Cite this

Paolini, M., Abdel-Rahman, S., Sapone, A., Pedulli, G. F., Perocco, P., Cantelli-Forti, G., & Legator, M. S. (2003). β-carotene: A cancer chemopreventive agent or a co-carcinogen? Mutation Research - Reviews in Mutation Research, 543(3), 195-200. https://doi.org/10.1016/S1383-5742(03)00002-4

β-carotene : A cancer chemopreventive agent or a co-carcinogen? / Paolini, Moreno; Abdel-Rahman, Sherif; Sapone, Andrea; Pedulli, Gian Franco; Perocco, Paolo; Cantelli-Forti, Giorgio; Legator, Marvin S.

In: Mutation Research - Reviews in Mutation Research, Vol. 543, No. 3, 06.2003, p. 195-200.

Research output: Contribution to journalArticle

Paolini, M, Abdel-Rahman, S, Sapone, A, Pedulli, GF, Perocco, P, Cantelli-Forti, G & Legator, MS 2003, 'β-carotene: A cancer chemopreventive agent or a co-carcinogen?', Mutation Research - Reviews in Mutation Research, vol. 543, no. 3, pp. 195-200. https://doi.org/10.1016/S1383-5742(03)00002-4
Paolini, Moreno ; Abdel-Rahman, Sherif ; Sapone, Andrea ; Pedulli, Gian Franco ; Perocco, Paolo ; Cantelli-Forti, Giorgio ; Legator, Marvin S. / β-carotene : A cancer chemopreventive agent or a co-carcinogen?. In: Mutation Research - Reviews in Mutation Research. 2003 ; Vol. 543, No. 3. pp. 195-200.
@article{e376009275774739b426e13b855f6d35,
title = "β-carotene: A cancer chemopreventive agent or a co-carcinogen?",
abstract = "Evidence from both epidemiological and experimental observations have fueled the belief that the high consumption of fruits and vegetables rich in carotenoids may help prevent cancer and heart disease in humans. Because of its well-documented antioxidant and antigenotoxic properties, the carotenoid β-carotene (βCT) gained most of the attention in the early 1980s and became one of the most extensively studied cancer chemopreventive agents in population-based trials supported by the National Cancer Institute. However, the results of three randomized lung cancer chemoprevention trials on βCT supplementation unexpectedly contradicted the large body of epidemiological evidence relating to the potential benefits of dietary carotenoids. Not only did βCT show no benefit, it was associated with significant increases in lung cancer incidence, cardiovascular diseases, and total mortality. These findings aroused widespread scientific debate that is still ongoing. It also raised the suspicion that βCT may even possess co-carcinogenic properties. In this review, we summarize the current data on the co-carcinogenic properties of βCT that is attributed to its role in the induction of carcinogen metabolizing enzymes and the over-generation of oxidative stress. The data presented provide convincing evidence of the harmful properties of this compound if given alone to smokers, or to individuals exposed to environmental carcinogens, as a micronutrient supplement. This has now been directly verified in a medium-term cancer transformation bioassay. In the context of public health policies, while the benefits of a diet rich in a variety of fruits and vegetables should continue to be emphasized, the data presented here point to the need for consideration of the possible detrimental effects of certain isolated dietary supplements, before mass cancer chemoprevention clinical trials are conducted on human subjects. This is especially important for genetically predisposed individuals who are environmentally or occupationally exposed to mutagens and carcinogens, such as those found in tobacco smoke and in industrial settings.",
keywords = "β-Carotene, Cancer, Chemopreventive agent",
author = "Moreno Paolini and Sherif Abdel-Rahman and Andrea Sapone and Pedulli, {Gian Franco} and Paolo Perocco and Giorgio Cantelli-Forti and Legator, {Marvin S.}",
year = "2003",
month = "6",
doi = "10.1016/S1383-5742(03)00002-4",
language = "English (US)",
volume = "543",
pages = "195--200",
journal = "Mutation Research - Reviews in Mutation Research",
issn = "1383-5742",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - β-carotene

T2 - A cancer chemopreventive agent or a co-carcinogen?

AU - Paolini, Moreno

AU - Abdel-Rahman, Sherif

AU - Sapone, Andrea

AU - Pedulli, Gian Franco

AU - Perocco, Paolo

AU - Cantelli-Forti, Giorgio

AU - Legator, Marvin S.

PY - 2003/6

Y1 - 2003/6

N2 - Evidence from both epidemiological and experimental observations have fueled the belief that the high consumption of fruits and vegetables rich in carotenoids may help prevent cancer and heart disease in humans. Because of its well-documented antioxidant and antigenotoxic properties, the carotenoid β-carotene (βCT) gained most of the attention in the early 1980s and became one of the most extensively studied cancer chemopreventive agents in population-based trials supported by the National Cancer Institute. However, the results of three randomized lung cancer chemoprevention trials on βCT supplementation unexpectedly contradicted the large body of epidemiological evidence relating to the potential benefits of dietary carotenoids. Not only did βCT show no benefit, it was associated with significant increases in lung cancer incidence, cardiovascular diseases, and total mortality. These findings aroused widespread scientific debate that is still ongoing. It also raised the suspicion that βCT may even possess co-carcinogenic properties. In this review, we summarize the current data on the co-carcinogenic properties of βCT that is attributed to its role in the induction of carcinogen metabolizing enzymes and the over-generation of oxidative stress. The data presented provide convincing evidence of the harmful properties of this compound if given alone to smokers, or to individuals exposed to environmental carcinogens, as a micronutrient supplement. This has now been directly verified in a medium-term cancer transformation bioassay. In the context of public health policies, while the benefits of a diet rich in a variety of fruits and vegetables should continue to be emphasized, the data presented here point to the need for consideration of the possible detrimental effects of certain isolated dietary supplements, before mass cancer chemoprevention clinical trials are conducted on human subjects. This is especially important for genetically predisposed individuals who are environmentally or occupationally exposed to mutagens and carcinogens, such as those found in tobacco smoke and in industrial settings.

AB - Evidence from both epidemiological and experimental observations have fueled the belief that the high consumption of fruits and vegetables rich in carotenoids may help prevent cancer and heart disease in humans. Because of its well-documented antioxidant and antigenotoxic properties, the carotenoid β-carotene (βCT) gained most of the attention in the early 1980s and became one of the most extensively studied cancer chemopreventive agents in population-based trials supported by the National Cancer Institute. However, the results of three randomized lung cancer chemoprevention trials on βCT supplementation unexpectedly contradicted the large body of epidemiological evidence relating to the potential benefits of dietary carotenoids. Not only did βCT show no benefit, it was associated with significant increases in lung cancer incidence, cardiovascular diseases, and total mortality. These findings aroused widespread scientific debate that is still ongoing. It also raised the suspicion that βCT may even possess co-carcinogenic properties. In this review, we summarize the current data on the co-carcinogenic properties of βCT that is attributed to its role in the induction of carcinogen metabolizing enzymes and the over-generation of oxidative stress. The data presented provide convincing evidence of the harmful properties of this compound if given alone to smokers, or to individuals exposed to environmental carcinogens, as a micronutrient supplement. This has now been directly verified in a medium-term cancer transformation bioassay. In the context of public health policies, while the benefits of a diet rich in a variety of fruits and vegetables should continue to be emphasized, the data presented here point to the need for consideration of the possible detrimental effects of certain isolated dietary supplements, before mass cancer chemoprevention clinical trials are conducted on human subjects. This is especially important for genetically predisposed individuals who are environmentally or occupationally exposed to mutagens and carcinogens, such as those found in tobacco smoke and in industrial settings.

KW - β-Carotene

KW - Cancer

KW - Chemopreventive agent

UR - http://www.scopus.com/inward/record.url?scp=0037674659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037674659&partnerID=8YFLogxK

U2 - 10.1016/S1383-5742(03)00002-4

DO - 10.1016/S1383-5742(03)00002-4

M3 - Article

C2 - 12787812

AN - SCOPUS:0037674659

VL - 543

SP - 195

EP - 200

JO - Mutation Research - Reviews in Mutation Research

JF - Mutation Research - Reviews in Mutation Research

SN - 1383-5742

IS - 3

ER -